Scott Ewan. Show Affiliations »
Abstract
Mesh： See more » Analgesics/chemistryAnalgesics/therapeutic useAnti-Obesity Agents/chemistryAnti-Obesity Agents/therapeutic useCannabinoids/chemistryCannabinoids/therapeutic useCannabis/chemistryClinical Trials as TopicHumansHydrophobic and Hydrophilic InteractionsInflammatory Bowel Diseases/drug therapyInflammatory Bowel Diseases/physiopathologyPiperidines/chemistryPiperidines/therapeutic usePyrazoles/chemistryPyrazoles/therapeutic useReceptor, Cannabinoid, CB1/antagonists & inhibitorsReceptor, Cannabinoid, CB1/physiologyReceptor, Cannabinoid, CB2/physiologyRimonabantSolubility
Substances： See more » AnalgesicsAnti-Obesity AgentsCannabinoidsO 1057PiperidinesPyrazolesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Rimonabant
Year: 2005 PMID： 16253865 DOI： 10.1016/S1359-6446(05)03628-7
Source DB: PubMed Journal: Drug Discov Today ISSN： 1359-6446 Impact factor: 7.851